title: Persistently elevated inflammatory markers and marked proteinuria due to Castleman disease.
authors.forename: Wojciech
authors.initials: W
authors.lastname: Jagiełło
authors.forename: Mamert
authors.initials: M
authors.lastname: Milewski
authors.forename: Krystyna
authors.initials: K
authors.lastname: Gałązka
authors.forename: Andrzej
authors.initials: A
authors.lastname: Budzyński
authors.forename: Jacek
authors.initials: J
authors.lastname: Musiał
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000209:etiology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000032:analysis* / Q000187:drug effects; D005871:Castleman Disease / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D008775:Methylprednisolone / Q000627:therapeutic use; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology*; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D002097:C-Reactive Protein; D008775:Methylprednisolone